关注
Boluwatife Afolabi
Boluwatife Afolabi
Biomedical Genomics, Tulane University
在 tulane.edu 的电子邮件经过验证
标题
引用次数
引用次数
年份
Computational study of the therapeutic potentials of a new series of imidazole derivatives against SARS-CoV-2
TO Johnson, AE Adegboyega, O Iwaloye, OA Eseola, W Plass, B Afolabi, ...
Journal of pharmacological sciences 147 (1), 62-71, 2021
422021
Neisseria gonorrhoeae Antimicrobial Resistance: Past to Present to Future
GL Aitolo, OS Adeyemi, BL Afolabi, AO Owolabi
Current Microbiology 78, 867-878, 2021
232021
The two sides of dietary antioxidants in cancer therapy
MA Akanji, HD Fatinukun, DE Rotimi, BL Afolabi, OS Adeyemi
IntechOpen, 2020
212020
Hypoxia and the kynurenine pathway: implications and therapeutic prospects in Alzheimer’s disease
OS Adeyemi, OJ Awakan, LB Afolabi, DE Rotimi, E Oluwayemi, ...
Oxidative Medicine and Cellular Longevity 2021 (1), 5522981, 2021
112021
Melanogenesis, its regulatory process, and insights on biomedical, biotechnological, and pharmacological potentials of melanin as antiviral biochemical
TH Fatoki, O Ibraheem, CJ Adeseko, BL Afolabi, DU Momodu, DM Sanni, ...
82020
Multi-omics data integration approach identifies potential biomarkers for Prostate cancer
Z Chikwambi, M Hidjo, P Chikondowa, G Jayeoba, V Aketch, L Afolabi, ...
bioRxiv, 2023.01. 26.522643, 2023
52023
Puerarin: A Review on the Pharmacological Activity, Chemical Properties and Pharmacokinetics of Main Isoflavonoid
BLA Oluwafemi Adeleke Ojo1*, Adebola Busola Ojo2 , Charles Obiora Nwonuma1 ...
The Natural Products Journal, 13, 2020
5*2020
Pharmacogenetics and adverse events in the use of fluoropyrimidine in a cohort of cancer patients on standard of care treatment in Zimbabwe
BL Afolabi, T Mazhindu, C Zedias, M Borok, N Ndlovu, C Masimirembwa, ...
Journal of Personalized Medicine 13 (4), 588, 2023
42023
COVID 19: Resveratrol as a Potential Supplement to Mitigate the Cardiotoxicity Associated with Chloroquine and Hydroxychloroquine Treatment
RD Emmanuel, AB Lawrence, AS Oluyomi
Biointerface Res. Appl. Chem 11, 11172-11186, 2021
42021
Differential immunomodulatory potential of silver nanoparticles and effect on the kynurenine pathway in male wistar rats
OS Adeyemi, LB Afolabi, DE Rotimi, FO Atanu, DS Ofume, T Ogunleye, ...
Journal of Nanomaterials 2022 (1), 9883142, 2022
32022
Nanomedicine for diabetes mellitus management
A Olatunde, H Tijjani, BL Afolabi, OA Ojo, SA Onikanni, BE Oyinloye, ...
Applications of Nanotechnology in Drug Discovery and Delivery, 179-203, 2022
22022
Comparative modulatory assessment of the sperm quality and testicular function by solvent fractions of the cannabis extract in rats
FG Oluwafemi
Pharmacognosy Journal 13 (6s), 2021
22021
Innovative and biocompatible approaches for nanomaterial production and application: Eco-friendly nanoscience
TC Elebiyo, D Rotimi, RM Asaleye, BB Afolabi, BT Atunwa, OS Adeyemi
Handbook of Research on Green Synthesis and Applications of Nanomaterials, 1-26, 2022
12022
Targeting of Hypoxia for Therapeutic Strategy in the Varied Physiological States
OS Adeyemi, LB Afolabi, DE Rotimi, DS Ofume, AA Adeyanju, OJ Awakan, ...
The Open Biochemistry Journal 16 (1), 2022
2022
on behalf of Consortium for Genomics and Therapeutics in Africa (CGTA). Pharmacogenetics and Adverse Events in the Use of Fluoropyrimidine in a Cohort of Cancer Patients on …
BL Afolabi, T Mazhindu, C Zedias, M Borok, N Ndlovu, C Masimirembwa
J. Pers. Med, 0
Filgotinib may be used as monotherapy or in combination with methotrexate. Menu
GL Aitolo, OS Adeyemi, BL Afolabi, AO Owolabi
系统目前无法执行此操作,请稍后再试。
文章 1–16